NCT00226564View on ClinicalTrials.gov

Genetic Determinants of Opioids Analgesia

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 1997

Conditions
Nephrolithiasis
Interventions
DRUG

Alfentanil

Trial Locations (1)

Unknown

Hadassah Medical Organization, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT00226564 - Genetic Determinants of Opioids Analgesia | Biotech Hunter | Biotech Hunter